Concepedia

Sanjeewani T. Palayoor

ST

31

Publications

1.9K

Citations

25

H-Index

1984

Active since

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

Harvard University

Dana-Farber Cancer Institute

National Institutes of Health

Sanjeewani T. Palayoor is an author at National Cancer Institute specializing in medicine, radiation oncology, and tumor biology.

Top concepts

Publications per year

1984–2017

31

Publications

31

Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen

Sanjeewani T. Palayoor, Matthew Youmell, Stuart K. Calderwood et al. · Oncogene · 1999 · 316 citations

, , +9

Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.

K. Rosenzweig, M B Youmell, Sanjeewani T. Palayoor et al. · PubMed · 1997 · 210 citations

, , +19

PX‐478, an inhibitor of hypoxia‐inducible factor‐1α, enhances radiosensitivity of prostate carcinoma cells

Sanjeewani T. Palayoor, James B. Mitchell, David Cerna et al. · International Journal of Cancer · 2008 · 126 citations · Full text

, , +17

Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers.

Christopher C. Benz, Max A. Keniry, James M. Ford et al. · Molecular Pharmacology · 1990 · 112 citations

Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells.

Sanjeewani T. Palayoor, Edward A. Bump, Stuart K. Calderwood et al. · PubMed · 1998 · 92 citations

, , +14

Rows per page

1–5 of 31